Cargando…
A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice
The binding of vascular endothelial growth factor (VEGF) to VEGF receptor-2 (VEGFR-2) on the surface of vascular endothelial cells stimulates many steps in the angiogenic pathway. Inhibition of this interaction is proving of value in moderating the neovascularization accompanying age-related macular...
Autores principales: | Chen, Yung-Yi, Brown, Nicola J., Jones, Rita, Lewis, Claire E., Mujamammi, Ahmed H., Muthana, Munitta, Seed, Michael P., Barker, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898417/ https://www.ncbi.nlm.nih.gov/pubmed/24129822 http://dx.doi.org/10.1007/s10456-013-9389-y |
Ejemplares similares
-
Specific Targeting of PEGylated Liposomal Doxorubicin (Doxil(®)) to Tumour Cells Using a Novel TIMP3 Peptide
por: Aldughaim, Mohammed S., et al.
Publicado: (2020) -
Coupling of a Novel TIMP3 Peptide to Carboxypeptidase G2 for Pro-Drug Activation at the Tumour Site
por: Aldughaim, Mohammed S., et al.
Publicado: (2021) -
Robust positive control of tumour growth using angiogenic inhibition
por: Homayounzade, Mohamadreza, et al.
Publicado: (2023) -
Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
por: Kwan, Amy, et al.
Publicado: (2021) -
Norovirus: An Overview of Virology and Preventative Measures
por: Winder, Natalie, et al.
Publicado: (2022)